Accueil
Marchés
Graphique & Idées
Algo
Nouvelles
Store
Courtiers
Télécharger
Calendrier Economique
Signaux de trading
Terminal Web
Tapez
/
pour rechercher : @user, $symbol
Recherche
Se connecter
Créer un compte
Français
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Italiano
Türkçe
WGS
#1574
GeneDx Holdings Corp. Class A Common Stock
79.7
1
+0.35%
Secteur:
Base:
Devise de Profit:
Range quotidien
Range Annuel
Changement quotidien
+0.35%
Changement Mensuel
-16.98%
Evolution sur 6 mois
-37.42%
Changement Annuel
-21.08%
Clôture Précédente
79.4
3
Open
79.7
1
Bid
Ask
Low
79.7
1
High
79.7
1
Volume
69
Marchés
Actions des Marchés US
Soins de Santé
WGS
Open full chart
Financials
Overview
Relevé
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
1.34 M
7.42 M
11.77 M
26.05 M
28.07 M
29.29 M
—
Valuation ratios
Enterprise value
—
—
—
-30.9 M
2.07 B
3.7 B
11.73 B
Price to earnings ratio
—
—
—
-0.37
-39.62
-178.16
2 056.29
Price to sales ratio
—
—
—
0.32
6.77
8.71
30.64
Price to cash flow ratio
—
—
—
-0.36
-72.53
111.94
-532.38
Price to book ratio
—
—
—
0.28
8.43
12.09
20.21
Enterprise value to EBITDA ratio
—
—
—
0.19
-135.39
3 125.99
3 265.68
Profitability ratios
Return on assets %
—
0.44
1.12
0.42
0.12
0.04
0.05
Return on equity %
—
0.63
2.16
0.77
0.21
0.07
0.08
Return on invested capital %
—
648.97
1 177.56
226.39
36.94
18.96
21.28
Gross margin %
—
7.82
11.4
44.19
63.64
69.74
278.22
Operating margin %
—
210.25
284.48
88.67
7.6
3.06
13.69
EBITDA margin %
—
-197.31
-269.16
-78.25
-5.01
0.28
-6.97
Net margin %
—
115.64
233.91
86.3
17.12
4.92
21.29
Liquidity ratios
Quick ratio
—
4.44
1.38
2.95
3.42
2.34
10.69
Current ratio
14.12
4.77
1.47
3.1
3.61
2.46
11.29
Inventory turnover
—
6.84
11.1
10.03
11.43
10.52
10.9
Asset turnover
—
0.43
0.45
0.45
0.73
0.91
0.91
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
0.02
0.01
0.13
0.12
0.09
0.42
Long term debt to total equity ratio
—
0.03
0.02
0.23
0.21
0.16
0.72
Per share metrics
Operating cash flow per share
—
58.15
31.18
7.41
1.06
1.16
1.15
EBIT per share
—
-134.5
-67.5
-7.37
-0.86
-0.29
-0.68
EBITDA per share
—
-127.84
-61.71
-6.56
-0.57
0.04
-0.35
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
122.32
12.1
5.35
5.25
5.98
21.54
Net current asset value per share
—
147.64
20.77
7.5
7.36
9.37
32.52
Tangible book value per share
—
118.5
6.55
2.28
3.22
4.41
14.69
Working capital per share
—
116.72
6.67
5.08
5.32
5.56
20.81
Book value per share
—
118.5
24.78
9.38
9.12
10.76
39.37
Nouvelles
GeneDx: The Growth Story Isn't Dead, It's Changing (Rating Upgrade) (NASDAQ:WGS)
These Analysts Slash Their Forecasts On GeneDx After Q4 Results - GeneDx Holdings (NASDAQ:WGS)
BTIG abaisse l’objectif de cours de GeneDx en raison de perspectives de croissance tardives
BTIG cuts GeneDx stock price target on back-end loaded growth outlook
GeneDx Holdings Corp. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:WGS) 2026-02-23
GeneDx Holdings Corp. (WGS) Q4 2025 Earnings Call Transcript
GeneDx T4 2025 : croissance du chiffre d’affaires de 54%, expansion agressive en 2026
GeneDx Q4 2025 slides: 54% revenue growth, aggressive 2026 expansion
Canaccord Genuity réitère sa recommandation d’achat sur GeneDx avec un objectif de 170$
GeneDx maintenu à l’achat par TD Cowen avant la publication des résultats
GeneDx stock maintained at Buy by TD Cowen ahead of results call
Canaccord Genuity reiterates Buy on GeneDx stock, keeps $170 target